AESKUSLIDES ANA HEp-2-Gamma, HELIOS FULLY AUTOMATED IFA SYSTEM

FDA 510(k) K153117 · Aesku Systems GmbH&Co.Kg

Substantially Equivalent

510(k) numberK153117

Submission

Device name
AESKUSLIDES ANA HEp-2-Gamma, HELIOS FULLY AUTOMATED IFA SYSTEM
Applicant
Aesku Systems GmbH&Co.Kg
Wendelsheim, DE
Received
October 28, 2015
Decision date
July 28, 2016
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DHN – Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5100
Specialty
Immunology

Other 510(k)s with product code DHN

510(k)DeviceApplicantDecision
K201956Zeus IFA ANA HEp-2 Test System, Zeus dIFineDHN · Traditional Zeus Scientific, Inc.04/29/2022SE
K172745ImmuGlo HEp-2 Elite IFADHN · Traditional Immco Diagnostics, Inc.06/05/2018SE
K160265Image Navigator by Immuno ConceptsDHN · Traditional Immuno Concepts, N.A. , Ltd.06/17/2016SE
K141827Euroimmun Ifa 40: HEP-20-10; Europattern Microscope and SoftwareDHN · Traditional Euroimmun Us, Inc.04/17/2015SE
K150155NOVA Lite DAPI ANA KitDHN · Traditional Inova Diagnostics, Inc.04/08/2015SE
K131791Ifa 40: HEP-20-10DHN · Traditional Euroimmun US02/26/2014SE
K120889Aeskuslides Ana HEP-2DHN · Traditional Aesku Diagnostics10/15/2012SE
K070763Euroimmun Ana Ifa: HEP-20-10DHN · Traditional Euroimmun Us, LLC05/22/2007SE
K042680Rhigene Hep-Ana Test SystemDHN · Traditional Corgenix, Inc.11/19/2004SE
K024220Liquichek Autoimmune Negative Control, Catalog #130DHN · Traditional Bio-Rad01/17/2003SE

Questions and answers

When was AESKUSLIDES ANA HEp-2-Gamma, HELIOS FULLY AUTOMATED IFA SYSTEM cleared by the FDA?

AESKUSLIDES ANA HEp-2-Gamma, HELIOS FULLY AUTOMATED IFA SYSTEM (K153117) received a 510(k) decision of Substantially Equivalent on July 28, 2016, 274 days after the submission was received.

What is the product code of K153117?

The FDA product code is DHN – Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5100.